Expertise in
1
conditions

Julien Geffrelot

Caen, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Caen, FR 

Overview

Julien Geffrelot practices practicing medicine in Caen, France.

Mr. Geffrelot is highly rated in 1 condition, according to our data. His clinical expertise encompasses Breast Cancer, Brain Tumor, Meningioma, Glioma, and Mastectomy.

He is actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Caen, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Circulating Immunes Cells, Cytokines and Brain Radiotherapy
Circulating Immunes Cells, Cytokines and Brain Radiotherapy
Enrollment Status: Recruiting
Publish Date: December 11, 2024
Intervention Type: Other
Study Phase: Not Applicable
Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Intervention Type: Drug
Study Drugs: Intensified Protocol, Stupp Protocol
Study Phase: Phase 3
Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Evaluation of the Impact of Emotional Skills of Young Women (≤ 45 Years), With Non-metastatic Breast Cancer, and Their Partner on Adjustment to Cancer
Enrollment Status: Completed
Publish Date: March 18, 2026
Intervention Type: Behavioral, Other
Study Phase: Not Applicable
Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)
Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)
Enrollment Status: Active_not_recruiting
Publish Date: March 18, 2026
Intervention Type: Procedure
Study Phase: Not Applicable
Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation
Study Drugs: Olaparib, Temozolomide (TMZ)
Study Phase: Phase 1/Phase 2
Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study
Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study
Enrollment Status: Completed
Publish Date: August 09, 2024
Intervention Type: Other
Study Phase: Not Applicable
Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol)
Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol)
Enrollment Status: Completed
Publish Date: March 08, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

30 Total Publications

Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial.
Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial.
Journal: International journal of radiation oncology, biology, physics
Published: March 06, 2025

Frequently Asked Questions about Julien Geffrelot

Is Julien Geffrelot a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Julien Geffrelot is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Julien Geffrelot participate in research or clinical trials?

Yes. Julien Geffrelot has published 30 articles and abstracts on conditions like Breast Cancer. You can view a list of Julien Geffrelot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Geffrelot's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile